The Current Ratio as of December 2025 (TTM) for Clinuvel Pharmaceuticals Limited (CLVLY) is 9.66

According to Clinuvel Pharmaceuticals Limited’s latest financial reports and current stock price. The company's current Current Ratio is 9.66. This represents a change of -9.46% compared to the average of 10.67 of the last 4 quarters.

Clinuvel Pharmaceuticals Limited (CLVLY) Historical Current Ratio (quarterly & annually)

How has CLVLY Current Ratio performed in the past?

The mean historical Current Ratio of Clinuvel Pharmaceuticals Limited over the last ten years is 9.93. The current 9.66 Current Ratio has changed 9.63% with respect to the historical average. Over the past ten years (40 quarters), CLVLY's Current Ratio was at its highest in in the June 2007 quarter at 26.90. The Current Ratio was at its lowest in in the December 2005 quarter at 0.

Clinuvel Pharmaceuticals Limited (CLVLY) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Clinuvel Pharmaceuticals Limited Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Clinuvel Pharmaceuticals Limited (CLVLY) Average Current Ratio

How has CLVLY Current Ratio performed in the past?

The current Current Ratio of Clinuvel Pharmaceuticals Limited (CLVLY) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Clinuvel Pharmaceuticals Limited (CLVLY) Current Ratio vs. Peers

How is CLVLY’s Current Ratio compared to its peers?

Clinuvel Pharmaceuticals Limited’s Current Ratio is greater than Northwest Biotherapeutics, Inc. (0.08), greater than Frontage Holdings Corporation (1.24), greater than PureTech Health plc (8.49), less than Immutep Limited (11.69), greater than Healios K.K. (1.06), greater than CytoDyn Inc. (0.19), greater than Ion Beam Applications S.A. (0.94), greater than Cellectis S.A. (1.38), greater than Avacta Group Plc (1.08), greater than BioInvent International AB (publ) (7.40),

Build a custom stock screener for Clinuvel Pharmaceuticals Limited (CLVLY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Clinuvel Pharmaceuticals Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Clinuvel Pharmaceuticals Limited (CLVLY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Clinuvel Pharmaceuticals Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.